Delivery of episomal vectors into primary cells by means of commercial transfection reagents

Abstract

Although episomal vectors are commonly transported into cells by electroporation, a number of electroporation-derived problems have led to the search for alternative transfection protocols, such as the use of transfection reagents, which are inexpensive and easy to handle. Polyplex-mediated transport of episomal vectors into the cytoplasm has been conducted successfully in immortalized cell lines, but no report exists of successful transfection of primary cells using this method. Accordingly, we sought to optimize the conditions for polyplex-mediated transfection for effective delivery of episomal vectors into the cytoplasm of primary mouse embryonic fibroblasts. Episomal vectors were complexed with the commercially available transfection reagents Lipofectamine 2000, FuGEND HD and jetPEI. The ratio of transfection reagent to episomal vectors was varied, and the subsequent transfection efficiency and cytotoxicity of the complexes were analyzed using flow cytometry and trypan blue exclusion assay, respectively. No cytotoxicity and the highest transfection yield were observed when the ratio of transfection reagent to episomal vector was 4 (v/wt) in the cases of Lipofectamine 2000 and FuGENE HD, and 2 in the case of jetPEI. Of the three transfection reagents tested, jetPEI showed the highest transfection efficiency without any cytotoxicity. Thus, we confirmed that the transfection reagent jetPEI could be used to effectively deliver episomal vectors into primary cells without electroporation.

TAOK1 negatively regulates IL-17-mediated signaling and inflammation

“…Illkirch, France) according to the manufacturer's protocols. 20 Control Non-target siRNA and TAOK1 on-target siRNA were obtained from Dharmacon (Thermo Fisher Scientific, Waltham, MA, USA). siRNA were transfected into HeLa cells with Lipofectamine RNAiMAX Basic information of human samples about non-IBD control and UC patients from Xinhua hospital.…”

Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes

“…As known, Lipofectamine™ 2000 contain lipid subunits that can form liposomes in an aqueous environment, composed of cationic phospholipids (dioleoylpropyl trimethyl ammonium chloride/dioleoylphosphatidylethanola mine =1/1), whose transfection efficacy for gene therapeutics has been well proved. 26,27 The transfection ability of fc-LPs was not inferior to that of Lipofectamine™ 2000 at all. Besides the low toxicity and cost, the high transfection efficacy rendered fc-LPs rather promising as nonviral vectors for HIF-1α siRNA delivery.…”

Effect of promoter, promoter mutation and enhancer on transgene expression mediated by episomal vectors in transfected HEK293, Chang liver and primary cells

“…A previous study demonstrated that the promoter activity is dependent on the cell type [40]. Although CMV promoters are commonly used for the high expression of transgenes in mammalian cells [41,42], they may be inappropriate promoters for strong expression in primary cells. The EF-1α promoter can drive transgene expression in primary cells, but the expression level needs to be further improved.…”